跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,578 条关于
“Replimune Group”
全部
26,578
临床试验
18,013
药物
554
机构
508
资讯
7,503
2年前
Replimune's RP1 Receives Positive FDA Feedback for Melanoma Treatment
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation and BLA Submission for Advanced Melanoma
去年
Replimune Presents Promising Data from IGNYTE Trial of RP1 in Solid Tumors
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
6年前
Replimune Enrolls First Patient in Phase 1 Clinical Trial of RP2 for Advanced Cancer
去年
Replimune Submits BLA for RP1 Melanoma Treatment, Gains FDA Breakthrough Therapy Designation
3个月前
Analysts Maintain Strong Buy Consensus on Eli Lilly Amid Conflicting Healthcare Sector Sentiments
去年
FDA Rejects Replimune's Melanoma Drug Amid Evolving Regulatory Standards
2年前
Replimune's RP1 Shows Durable Responses in Anti-PD1 Failed Melanoma
第 1 页,共 751 页
上一页
下一页